Novavax Inc (NASDAQ:NVAX)
| 189.01 Delayed Data As of Jul 28 |  +10.00 / +5.59%Today’s Change | 76.59 Today|||52-Week Range 331.68 | +69.50% Year-to-Date |
Latest NVAX News | Press Releases
Today’s Trading
| Previous close | 179.01 |
| Today’s open | 185.66 |
| Day’s range | 180.37 - 190.50 |
| Volume | 104,196 |
| Average volume (3 months) | 3,853,006 |
| Market cap | $15.0B |
Data as of 7:45pm ET, 07/28/2021
Growth & Valuation
| Earnings growth (last year) | -31.99% |
| Earnings growth (this year) | +11.66% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +2,448.48% |
| P/E ratio | NM |
| Price/Sales | 13.49 |
| Price/Book | 22.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BMRNBiomarin Pharmaceuti... | +0.33 | +0.42% |
| ZLABZai Lab Ltd | +26.57 | +22.91% |
| NTLAIntellia Therapeutic... | +3.91 | +2.95% |
| CRSPCRISPR Therapeutics ... | +2.49 | +2.12% |
Data as of 4:44pm ET, 07/28/2021
Financials
| Next reporting date | August 6, 2021 |
| EPS forecast (this quarter) | -$3.63 |
| Annual revenue (last year) | $475.6M |
| Annual profit (last year) | -$418.3M |
| Net profit margin | -87.94% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
